BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ando K, Oki E, Saeki H, Yan Z, Tsuda Y, Hidaka G, Kasagi Y, Otsu H, Kawano H, Kitao H, Morita M, Maehara Y. Discrimination of p53 immunohistochemistry-positive tumors by its staining pattern in gastric cancer. Cancer Med. 2015;4:75-83. [PMID: 25354498 DOI: 10.1002/cam4.346] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Chen L, Liu Y, Zhang Q, Zhang M, Han X, Li Q, Xie T, Wu Q, Sui X. p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder Cancer. J Cancer 2019;10:6207-16. [PMID: 31772653 DOI: 10.7150/jca.37335] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Zhu Y, Zhu X, Xue X, Zhang Y, Hu C, Liu W, Lu H. Exploration of High-Grade Transformation and Postoperative Radiotherapy on Prognostic Analysis for Primary Adenoid Cystic Carcinoma of the Head and Neck. Front Oncol 2021;11:647172. [PMID: 33898317 DOI: 10.3389/fonc.2021.647172] [Reference Citation Analysis]
3 Liu S, Joseph NM, Ravindranathan A, Stohr BA, Greenland NY, Vohra P, Hosfield E, Yeh I, Talevich E, Onodera C, Van Ziffle JA, Grenert JP, Bastian BC, Chen Y, Krings G. Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity. Mod Pathol 2016;29:1012-27. [DOI: 10.1038/modpathol.2016.97] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
4 Shin YJ, Kim Y, Wen X, Cho NY, Lee S, Kim WH, Kang GH. Prognostic implications and interaction of L1 methylation and p53 expression statuses in advanced gastric cancer. Clin Epigenetics. 2019;11:77. [PMID: 31088544 DOI: 10.1186/s13148-019-0661-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
5 Inoue Y, Yamashita N, Kitao H, Tanaka K, Saeki H, Oki E, Oda Y, Tokunaga E, Maehara Y. Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer. Clin Breast Cancer 2018;18:e643-50. [PMID: 29275106 DOI: 10.1016/j.clbc.2017.11.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ibáñez-Redín G, Joshi N, do Nascimento GF, Wilson D, Melendez ME, Carvalho AL, Reis RM, Gonçalves D, Oliveira ON Jr. Determination of p53 biomarker using an electrochemical immunoassay based on layer-by-layer films with NiFe2O4 nanoparticles. Mikrochim Acta 2020;187:619. [PMID: 33083850 DOI: 10.1007/s00604-020-04594-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
7 Romero-Calvo I, Weber CR, Ray M, Brown M, Kirby K, Nandi RK, Long TM, Sparrow SM, Ugolkov A, Qiang W, Zhang Y, Brunetti T, Kindler H, Segal JP, Rzhetsky A, Mazar AP, Buschmann MM, Weichselbaum R, Roggin K, White KP. Human Organoids Share Structural and Genetic Features with Primary Pancreatic Adenocarcinoma Tumors. Mol Cancer Res 2019;17:70-83. [PMID: 30171177 DOI: 10.1158/1541-7786.MCR-18-0531] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
8 Cerda-Opazo P, Valenzuela-Valderrama M, Wichmann I, Rodríguez A, Contreras-Reyes D, Fernández EA, Carrasco-Aviño G, Corvalán AH, Quest AFG. Inverse expression of survivin and reprimo correlates with poor patient prognosis in gastric cancer. Oncotarget 2018;9:12853-67. [PMID: 29560115 DOI: 10.18632/oncotarget.24402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Murnyák B, Hortobágyi T. Immunohistochemical correlates of TP53 somatic mutations in cancer. Oncotarget 2016;7:64910-20. [PMID: 27626311 DOI: 10.18632/oncotarget.11912] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 18.0] [Reference Citation Analysis]
10 Saito T, Chambers JK, Nakashima K, Nibe K, Ohno K, Tsujimoto H, Uchida K, Nakayama H. Immunohistochemical analysis of beta-catenin, E-cadherin and p53 in canine gastrointestinal epithelial tumors. J Vet Med Sci 2020;82:1277-86. [PMID: 32655099 DOI: 10.1292/jvms.20-0297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Schoop I, Maleki SS, Behrens HM, Krüger S, Haag J, Röcken C. p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohort. Hum Pathol 2020;105:53-66. [PMID: 32971129 DOI: 10.1016/j.humpath.2020.09.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Lee H, Lee HH, Lim CY, Lee J. The utility of high-mobility group A2 overexpression for predicting the prognosis of gastric cancer patients and its contribution to poor prognosis via chemoresistance and the propensity for the occurrence of carcinomatosis peritonei. Surgery 2021;169:1213-20. [PMID: 33376002 DOI: 10.1016/j.surg.2020.11.020] [Reference Citation Analysis]
13 Ali AS, Grönberg M, Federspiel B, Scoazec JY, Hjortland GO, Grønbæk H, Ladekarl M, Langer SW, Welin S, Vestermark LW, Arola J, Österlund P, Knigge U, Sorbye H, Grimelius L, Janson ET. Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma. PLoS One 2017;12:e0187667. [PMID: 29112960 DOI: 10.1371/journal.pone.0187667] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
14 Yuan T, Ying J, Zuo Z, Jin L, Gui S, Gao Z, Li G, Wang R, Zhang Y, Li C. Contrahemispheric Cortex Predicts Survival and Molecular Markers in Patients With Unilateral High-Grade Gliomas. Front Oncol 2020;10:953. [PMID: 32793462 DOI: 10.3389/fonc.2020.00953] [Reference Citation Analysis]
15 Vital D, Huber GF, Holzmann D, Moch H, Ikenberg K. The presence of aberrant p53 pattern is a negative prognostic predictor in squamous cell carcinoma of the nasal vestibule. Eur Arch Otorhinolaryngol 2017;274:3503-12. [PMID: 28669050 DOI: 10.1007/s00405-017-4659-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
16 Tsuruta S, Ohishi Y, Fujiwara M, Ihara E, Ogawa Y, Oki E, Nakamura M, Oda Y. Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist. Hum Pathol 2019;88:27-38. [PMID: 30946937 DOI: 10.1016/j.humpath.2019.03.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
17 Kim KW, Kim N, Choi Y, Kim WS, Yoon H, Shin CM, Park YS, Lee DH, Park YS, Ahn SH, Park DJ, Kim HH, Lee HS, Kim JW, Kim JW, Lee KW, Chang W, Park JH, Lee YJ, Lee KH, Kim YH. Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study. Gastric Cancer 2021;24:844-57. [PMID: 33598811 DOI: 10.1007/s10120-021-01163-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Imamura T, Komatsu S, Ichikawa D, Miyamae M, Okajima W, Ohashi T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E. Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinoma. Carcinogenesis 2018;39:263-71. [PMID: 29228320 DOI: 10.1093/carcin/bgx139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
19 Qin L, Jia Z, Xie D, Liu Z. Knockdown of long noncoding RNA urothelial carcinoma-associated 1 inhibits cell viability, migration, and invasion by regulating microRNA-182 in gastric carcinoma. J Cell Biochem 2018;119:10075-86. [PMID: 30129054 DOI: 10.1002/jcb.27344] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
20 Ramos MFKP, Pereira MA, de Mello ES, Cirqueira CDS, Zilberstein B, Alves VAF, Ribeiro-Junior U, Cecconello I. Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery. World J Clin Oncol 2021; 12(8): 688-701 [PMID: 34513602 DOI: 10.5306/wjco.v12.i8.688] [Reference Citation Analysis]
21 Ramsauer AS, Wachoski-Dark GL, Fraefel C, Tobler K, Brandt S, Knight CG, Favrot C, Grest P. Paving the way for more precise diagnosis of EcPV2-associated equine penile lesions. BMC Vet Res 2019;15:356. [PMID: 31640696 DOI: 10.1186/s12917-019-2097-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
22 Yang Z, Ma J, Qi G, Zhang X. Type 2 Diabetes Associated with Abnormal p53 Immunohistochemical Patterns in Colorectal Cancer. Cancer Invest 2021;39:73-83. [PMID: 33191800 DOI: 10.1080/07357907.2020.1852411] [Reference Citation Analysis]
23 Cobzeanu BM, Cobzeanu MD, Moscalu M, Palade OD, Rădulescu L, Negru D, Moisii LG, Cobzeanu LM, Ungureanu LB, Vonica P, Matei DV, Rusu DC, Volovaț C, Costan VV. Predictive Value of HPV, p53, and p16 in the Post-Treatment Evolution of Malignant Tumors of the Oropharynx and Retromolar Trigone-Oropharynx Junction. Medicina (Kaunas) 2020;56:E542. [PMID: 33076537 DOI: 10.3390/medicina56100542] [Reference Citation Analysis]
24 Daun T, Nienhold R, Paasinen-Sohns A, Frank A, Sachs M, Zlobec I, Cathomas G. Combined Simplified Molecular Classification of Gastric Adenocarcinoma, Enhanced by Lymph Node Status: An Integrative Approach. Cancers (Basel) 2021;13:3722. [PMID: 34359622 DOI: 10.3390/cancers13153722] [Reference Citation Analysis]
25 Li L, Chen W, Yan Z, Feng J, Hu S, Liu B, Liu X. Comparative Analysis of Amide Proton Transfer MRI and Diffusion-Weighted Imaging in Assessing p53 and Ki-67 Expression of Rectal Adenocarcinoma. J Magn Reson Imaging 2020;52:1487-96. [PMID: 32524685 DOI: 10.1002/jmri.27212] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Mai KT. Does Differentiated Squamous Intraepithelial Neoplasia Occur in the Cervix? Appl Immunohistochem Mol Morphol 2018;26:e52-60. [PMID: 28877072 DOI: 10.1097/PAI.0000000000000577] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Ramsauer AS, Wachoski-Dark GL, Fraefel C, Ackermann M, Brandt S, Grest P, Knight CG, Favrot C, Tobler K. Establishment of a Three-Dimensional In Vitro Model of Equine Papillomavirus Type 2 Infection. Viruses 2021;13:1404. [PMID: 34372610 DOI: 10.3390/v13071404] [Reference Citation Analysis]
28 Matuszczak M, Salagierski M. Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers. Int J Mol Sci 2020;21:E3360. [PMID: 32397531 DOI: 10.3390/ijms21093360] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Małusecka E, Chmielik E, Suwiński R, Giglok M, Lange D, Rutkowski T, Mazurek AM. Significance of HPV16 Viral Load Testing in Anal Cancer. Pathol Oncol Res 2020;26:2191-9. [PMID: 32266586 DOI: 10.1007/s12253-020-00801-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Setia N, Agoston AT, Han HS, Mullen JT, Duda DG, Clark JW, Deshpande V, Mino-Kenudson M, Srivastava A, Lennerz JK, Hong TS, Kwak EL, Lauwers GY. A protein and mRNA expression-based classification of gastric cancer. Mod Pathol. 2016;29:772-784. [PMID: 27032689 DOI: 10.1038/modpathol.2016.55] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 14.2] [Reference Citation Analysis]
31 Calvocoressi L, Uchio E, Ko J, Radhakrishnan K, Aslan M, Concato J. Prostate cancer aggressiveness and age: Impact of p53, BCL-2 and microvessel density. J Investig Med 2018;66:1142-6. [DOI: 10.1136/jim-2018-000804] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
32 Sun J, Lin L, Zhang J, Hu C, Wang J. The prognostic value of USP7 and p53 in advanced hypopharyngeal carcinoma. Ann Diagn Pathol 2021;51:151695. [PMID: 33460997 DOI: 10.1016/j.anndiagpath.2020.151695] [Reference Citation Analysis]
33 Nshizirungu JP, Bennis S, Mellouki I, Sekal M, Benajah DA, Lahmidani N, El Bouhaddouti H, Ibn Majdoub K, Ibrahimi SA, Celeiro SP, Viana-Pereira M, Munari FF, Ribeiro GG, Duval V, Santana I, Reis RM. Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients. Dis Markers 2021;2021:9980410. [PMID: 34367379 DOI: 10.1155/2021/9980410] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Horwitz DA, Fahmy TM, Piccirillo CA, La Cava A. Rebalancing Immune Homeostasis to Treat Autoimmune Diseases. Trends Immunol 2019;40:888-908. [PMID: 31601519 DOI: 10.1016/j.it.2019.08.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
35 Mamlouk S, Simon T, Tomás L, Wedge DC, Arnold A, Menne A, Horst D, Capper D, Morkel M, Posada D, Sers C, Bläker H. Malignant transformation and genetic alterations are uncoupled in early colorectal cancer progression. BMC Biol 2020;18:116. [PMID: 32895052 DOI: 10.1186/s12915-020-00844-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Li Y, Qian Z, Xu K, Wang K, Fan X, Li S, Jiang T, Liu X, Wang Y. MRI features predict p53 status in lower-grade gliomas via a machine-learning approach. Neuroimage Clin 2018;17:306-11. [PMID: 29527478 DOI: 10.1016/j.nicl.2017.10.030] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 11.8] [Reference Citation Analysis]
37 Gurzu S, Jung I, Sugimura H, Stefan-van Staden RI, Yamada H, Natsume H, Iwashita Y, Szodorai R, Szederjesi J. Maspin subcellular expression in wild-type and mutant TP53 gastric cancers. World J Gastrointest Oncol 2020; 12(7): 741-755 [PMID: 32864042 DOI: 10.4251/wjgo.v12.i7.741] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
38 Gonzalez RS, Messing S, Tu X, McMahon LA, Whitney-Miller CL. Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma.Hum Pathol. 2016;56:16-21. [PMID: 27342907 DOI: 10.1016/j.humpath.2016.06.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]